Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: John O'Neill who wrote (17472)	3/15/1998 9:05:00 PM
From: Andrew H	Respond to of 32384

Well, John, I've always got an opinion. Its pretty hard to say what will happen to LGND in the shorter term with the news of the Panretin filing, but by the end of the year, I expect the stock will be at least between 25-30. I don't think we will see a lot of selling on the news. On the other hand, it wouldn't surprise me if we didn't see a lot of buying either. However, with the considerable good news to follow for the rest of the year, we should trend inevitably higher.

To: John O'Neill who wrote (17472)	3/16/1998 8:31:00 AM
From: tonyt	Respond to of 32384

This stock has always been a 'sell on the news' trading stock that has never stayed above $18 for long. Maybe this time will be different? I wouldn't bet on it.